There were 859 press releases posted in the last 24 hours and 185,455 in the last 365 days.
Protein Inhibitors Global Market Report 2022– Market Size, Trends, And Global Forecast 2022-2026
The Business Research Company’s Protein Inhibitors Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026
LONDON, GREATER LONDON, UK, March 7, 2022 /EINPresswire.com/ — The increasing prevalence of chronic diseases is predicted to contribute to the growth of the global protein inhibitors market over the forecast period. Chronic diseases such as cancer, cardiovascular diseases, and autoimmune diseases are becoming more prevalent. According to the World Health Organization, chronic diseases are expected to become the seventh leading cause of death globally by the end of 2030. In the USA, the number reached 157 million in 2020, with 87 million people having multiple conditions. Protein inhibitors are used for the treatment of these diseases attributing to fewer adverse effects and higher efficacy. Therefore, an increasing number of people with chronic diseases are anticipated to propel the protein inhibitors market growth.
The global protein inhibitors market size is expected to grow from $62.54 billion in 2021 to $68.17 billion in 2022 at a compound annual growth rate (CAGR) of 9.0%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The protein inhibitor market is expected to reach $96.73 billion in 2026 at a CAGR of 9.1%.
Read more on the Global Protein Inhibitors Market Report:
Companies in the protein inhibitors market are increasingly investing in various strategic initiatives such as partnerships and collaborations to develop new drugs to meet the market demand. Protein inhibitors market trends include strategic collaborations and partnership agreements help companies to expand their existing product portfolio and geographical presence. For instance, in February 2020, Catalent, Inc., a USA-based provider of delivery technologies, drug manufacturing, gene therapies, biologics, and consumer healthcare products announced the partnership agreement with Zumutor Biologics Inc., an immune-oncology company based in the USA to manufacture ZM008, a monoclonal antibody targeting solid tumors. Moreover, in February 2021, Eli Lilly and Company, a USA-based pharmaceutical company, and Rigel Pharmaceuticals, Inc, a USA-based biotechnology company, announced a global exclusive licence agreement and strategic collaboration to co-develop and commercialize Rigel's R552, a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor, for all indications, including autoimmune and inflammatory diseases.
Major players covered in the global protein inhibitors industry are Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, Glaxosmithkline, Pfizer, Boehringer Ingelheim and F. Hoffmann-La Roche.
TBRC’s global protein inhibitors market report is segmented by product into protein kinase inhibitors, monoclonal antibody, others, by application into oncology, inflammatory diseases, others, by distribution channel into hospital pharmacies, independent pharmacies, online pharmacies.
Protein Inhibitors Global Market Report 2022 – By Product (Protein Kinase Inhibitors, Monoclonal Antibody), By Application (Oncology, Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides a protein inhibitors market overview, forecast protein inhibitors market size and growth for the whole market, protein inhibitors market segments, geographies, protein inhibitors market trends, protein inhibitors market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request for a Sample of the Global Protein Inhibitors Market Report:
Not what you were looking for? Here is a list of similar reports by The Business Research Company:
Protein Expression Global Market Report 2022 – By Protein Expression (Yeast Expression, Mammalian Expression, Algae Expression, Insect Expression, Bacterial Expression, Cell-free Expression), By End Use (Pharmaceutical And Biotechnological Companies, Academic Research, Contract Research Organizations), By Product (Reagents, Competent Cells, Expression vectors, Services, Instruments), By Application (Therapeutic, Industrial, Research) – Market Size, Trends, And Global Forecast 2022-2026
Proteomics Global Market Report 2022 – By Component (Reagents, Instruments), By Instrument (Protein Microarrays, Spectroscopy, X-ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation), By Service and Software (Core Proteomics Services, Bioinformatics Software & Services) – Market Size, Trends, And Global Forecast 2022-2026
Biologics Global Market Report 2022 – By Type (Monoclonal Antibodies (MAbs), Therapeutic Proteins, Vaccines), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
Know More About The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Check out our:
The Business Research Company
+44 20 7193 0708
Visit us on social media:
Market Research Products, Services, Solutions For Your Business – TBRC
You just read:
EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™, tries to define some of the boundaries that are reasonable in today’s world. Please see our Editorial Guidelines for more information.
Follow EIN Presswire
© 1995-2022 IPD Group, Inc. dba EIN Presswire
All Right Reserved.